Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 22, 2016 06:00 ET | Source: Gemphire Therapeutics

Gemphire Therapeutics to Present Corporate Overview at the Ladenburg Thalmann 2016 Healthcare Conference

LIVONIA, Mich., Sept. 22, 2016 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (Nasdaq:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for the...
September 19, 2016 06:00 ET | Source: Gemphire Therapeutics

Gemphire Therapeutics Announces Publication of Phase 2 Data for Gemcabene in the Journal of Clinical Lipidology

LIVONIA, Mich., Sept. 19, 2016 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (Nasdaq:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for the...
August 10, 2016 16:05 ET | Source: Gemphire Therapeutics

Gemphire Therapeutics Announces Closing of Initial Public Offering

NORTHVILLE, Mich., Aug. 10, 2016 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (Nasdaq:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for...
August 04, 2016 17:57 ET | Source: Gemphire Therapeutics

Gemphire Therapeutics Announces Pricing of Initial Public Offering

NORTHVILLE, Mich., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for the treatment of...